» Articles » PMID: 16951933

Idiopathic Membranous Nephropathy in Children

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2006 Sep 5
PMID 16951933
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic membranous nephropathy (MN) is a rare cause of asymptomatic proteinuria (AP) or nephrotic syndrome (NS) in childhood. To improve our understanding of its clinical course, we retrospectively reviewed 19 cases of idiopathic MN seen in our hospital over a period of 28.5 years, i.e., from January 1977 to July 2005. Eight patients (39%) had AP and 11 (61%) presented with NS. All eight AP patients achieved remission, regardless of treatment modality. Oral corticosteroid was given to all 11 NS patients, but only three of them responded to corticosteroid. Of the eight steroid non-responders, three achieved remissions with the addition of cyclosporine, and the five who were not administered additional immunosuppressive drugs had persistent NS. At the latest evaluation, all six NS patients that achieved remission remained free of proteinuria and had a normal renal function. Moreover, two of the 5 steroid non-responders showed persistent nephrotic-range proteinuria but a stable renal function. The remaining three steroid non-responders progressed into chronic renal insufficiency, and this progression was preceded by renal vein thrombosis (RVT) in two of the three patients. Presentation with NS (P=0.045) and the development of RVT (P=0.010) were identified as poor prognostic factors.

Citing Articles

The Clinical Profile and Long-Term Outcome of Children with Membranous Nephropathy, and the Evaluation of Anti-Phospholipase A2 Receptor Antibody Immunohistochemistry in Kidney Biopsy.

Deepthi R, George S, Mathew G, Roy S, Bindra M, Rebekah G Indian J Nephrol. 2024; 33(6):432-439.

PMID: 38174298 PMC: 10752404. DOI: 10.4103/ijn.ijn_228_22.


How to Choose the Right Treatment for Membranous Nephropathy.

Peritore L, Labbozzetta V, Maressa V, Casuscelli C, Conti G, Gembillo G Medicina (Kaunas). 2023; 59(11).

PMID: 38004046 PMC: 10673286. DOI: 10.3390/medicina59111997.


Pediatric membranous nephropathy: In the novel antigens era.

Huang G, Liu F, Yu L, Wang J, Chen J, Mao J Front Immunol. 2022; 13:962502.

PMID: 36016931 PMC: 9396344. DOI: 10.3389/fimmu.2022.962502.


Treatment Patterns Among Adults and Children With Membranous Nephropathy in the Cure Glomerulonephropathy Network (CureGN).

OShaughnessy M, Troost J, Bomback A, Hladunewich M, Ashoor I, Gibson K Kidney Int Rep. 2019; 4(12):1725-1734.

PMID: 31844809 PMC: 6895579. DOI: 10.1016/j.ekir.2019.09.005.


Chapter 7: Idiopathic membranous nephropathy.

Kidney Int Suppl (2011). 2014; 2(2):186-197.

PMID: 25018932 PMC: 4089709. DOI: 10.1038/kisup.2012.20.


References
1.
Cameron J, Healy M, Adu D . The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med. 1990; 74(274):133-56. View

2.
Lee H, Choi Y, Yu S, Koh H, Kim M, KO K . A renal biopsy study of hepatitis B virus-associated nephropathy in Korea. Kidney Int. 1988; 34(4):537-43. DOI: 10.1038/ki.1988.215. View

3.
Perna A, Schieppati A, Zamora J, Giuliano G, Braun N, Remuzzi G . Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis. 2004; 44(3):385-401. View

4.
OLBING H, GREIFER I, Bennett B, Bernstein J, Spitzer A . Idiopathic membranous nephropathy in children. Kidney Int. 1973; 3(6):381-90. DOI: 10.1038/ki.1973.60. View

5.
Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C . A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1989; 320(1):8-13. DOI: 10.1056/NEJM198901053200102. View